New situation and new strategies research and development and internationalization of new drugs and health products of traditional Chinese medicine

Ning Jiang; Chun Hui Ql; Liang Cao; Lan Ying Chen; Jin Hui Gu; Yong Kang; Kim Inkyeom; Xiao Yuan Lian; Yin Lu; Gui Yuan Lyu; Ke Nie; Yun Ql; Schini Kerth Valerie; Spedding Michael; Wainwright Cherry; Yue Hua Wang; Wei Xiao; Yong Yang; Lin Zhong Yu; Dan Shen Zhang; Yong He Zhang; Wen Xia Zhou; Guan Hua Du; Yong Xiang Zhang

doi:10.3867/j.issn.1000-3002.2018.01.001

New situation and new strategies research and development and internationalization of new drugs and health products of traditional Chinese medicine

Ning Jiang, Chun Hui Ql, Liang Cao, Lan Ying Chen, Jin Hui Gu, Yong Kang, Kim Inkyeom, Xiao Yuan Lian, Yin Lu, Gui Yuan Lyu, Ke Nie, Yun Ql, Schini Kerth Valerie, Spedding Michael, Wainwright Cherry, Yue Hua Wang, Wei Xiao, Yong Yang, Lin Zhong Yu, Dan Shen ZhangYong He Zhang, Wen Xia Zhou, Guan Hua Du, Yong Xiang Zhang

Department of Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

The 2017 China (Lianyungang) International Medical Technology Conference v/as held in Lianyungang. Jiangsu Province during November 15-17, 2017. During this conference, the Division for Traditional Chinese Medicine and Natural Products Pharmacology of Chinese Pharmacological Society (CNPHARS) and Jiangsu Kanion Pharmaceutical Co. Ltd. jointly held the Forum on R&D and Internationalization of New Drugs and Health Products of Traditional Chinese Medicine. The forum was co-chaired by Professor ZHANG Yong- xiang, President of CNPHARS, Chair of Division for Tradhional Chinese Medicine and Natural Products Pharmacology of CNPHARS, and Chair of the Natural Product Section of International Union of Basic & Clinical Pharmacology (IUPHAR), Professor DU Guan-hua, former President of CNPHARS and Vice-Chair of Division for Traditional Chinese Medtane and Natural Prodjcts Pharmacology of CNPHARS. and Dr. XIAO Wei. Chairman of the Board of Jiangsu Kanion Pharmaceutical Co. Ltd. and Vice-Chair of Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS. More than 70 scholars attended the forum, including four foreign experts [Michael SPEDDING. Secretary- General ol IUPHAR; Professor Valerie B. SCHINI-KERTH, Vice-Chair of the Natural Product Section of IUPHAR; Professor Cherry WAINWRGHT. Director of Centre for Natural Product Drugs of Robert Gordon University; Professor InKyeom KIM, Director of the Korean Society of Pharmacology], members of the Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS and leading researchers at Jiangsu Kanion Pharmaceutical Co., Ltd. GU Jin-hui, Director of the Division of National Science and Technology Major Project for Drug Innovation, Department of Health Science, Technology and Education, National Health and Family Planning Commission of the People's Republic of China v/as also invited to attend the forum. Representatives discussed the R&D and internationalization of new drugs and health products of traditional Chinese medicine. The summary of views and advice of some experts was published here for the purpose of promoting domestic and overseas academic exchange, and playing an active role in improving the level of R&D and internationalization of new drugs and health products of traditional Chinese medicine In China.

Original language	English
Pages (from-to)	1-50
Number of pages	50
Journal	Chinese Journal of Pharmacology and Toxicology
Volume	32
Issue number	1
DOIs	https://doi.org/10.3867/j.issn.1000-3002.2018.01.001
State	Published - Jun 2018

Keywords

Health products
Internationalization
New drugs
Traditional Chinese medicine

Access to Document

10.3867/j.issn.1000-3002.2018.01.001

Cite this

Jiang, N., Ql, C. H., Cao, L., Chen, L. Y., Gu, J. H., Kang, Y., Inkyeom, K., Lian, X. Y., Lu, Y., Lyu, G. Y., Nie, K., Ql, Y., Valerie, S. K., Michael, S., Cherry, W., Wang, Y. H., Xiao, W., Yang, Y., Yu, L. Z., ... Zhang, Y. X. (2018). New situation and new strategies research and development and internationalization of new drugs and health products of traditional Chinese medicine. Chinese Journal of Pharmacology and Toxicology, 32(1), 1-50. https://doi.org/10.3867/j.issn.1000-3002.2018.01.001

@article{2c13ec25bbaf43c5890cd5e08eca819a,

title = "New situation and new strategies research and development and internationalization of new drugs and health products of traditional Chinese medicine",

abstract = "The 2017 China (Lianyungang) International Medical Technology Conference v/as held in Lianyungang. Jiangsu Province during November 15-17, 2017. During this conference, the Division for Traditional Chinese Medicine and Natural Products Pharmacology of Chinese Pharmacological Society (CNPHARS) and Jiangsu Kanion Pharmaceutical Co. Ltd. jointly held the Forum on R&D and Internationalization of New Drugs and Health Products of Traditional Chinese Medicine. The forum was co-chaired by Professor ZHANG Yong- xiang, President of CNPHARS, Chair of Division for Tradhional Chinese Medicine and Natural Products Pharmacology of CNPHARS, and Chair of the Natural Product Section of International Union of Basic & Clinical Pharmacology (IUPHAR), Professor DU Guan-hua, former President of CNPHARS and Vice-Chair of Division for Traditional Chinese Medtane and Natural Prodjcts Pharmacology of CNPHARS. and Dr. XIAO Wei. Chairman of the Board of Jiangsu Kanion Pharmaceutical Co. Ltd. and Vice-Chair of Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS. More than 70 scholars attended the forum, including four foreign experts [Michael SPEDDING. Secretary- General ol IUPHAR; Professor Valerie B. SCHINI-KERTH, Vice-Chair of the Natural Product Section of IUPHAR; Professor Cherry WAINWRGHT. Director of Centre for Natural Product Drugs of Robert Gordon University; Professor InKyeom KIM, Director of the Korean Society of Pharmacology], members of the Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS and leading researchers at Jiangsu Kanion Pharmaceutical Co., Ltd. GU Jin-hui, Director of the Division of National Science and Technology Major Project for Drug Innovation, Department of Health Science, Technology and Education, National Health and Family Planning Commission of the People's Republic of China v/as also invited to attend the forum. Representatives discussed the R&D and internationalization of new drugs and health products of traditional Chinese medicine. The summary of views and advice of some experts was published here for the purpose of promoting domestic and overseas academic exchange, and playing an active role in improving the level of R&D and internationalization of new drugs and health products of traditional Chinese medicine In China.",

keywords = "Health products, Internationalization, New drugs, Traditional Chinese medicine",

author = "Ning Jiang and Ql, {Chun Hui} and Liang Cao and Chen, {Lan Ying} and Gu, {Jin Hui} and Yong Kang and Kim Inkyeom and Lian, {Xiao Yuan} and Yin Lu and Lyu, {Gui Yuan} and Ke Nie and Yun Ql and Valerie, {Schini Kerth} and Spedding Michael and Wainwright Cherry and Wang, {Yue Hua} and Wei Xiao and Yong Yang and Yu, {Lin Zhong} and Zhang, {Dan Shen} and Zhang, {Yong He} and Zhou, {Wen Xia} and Du, {Guan Hua} and Zhang, {Yong Xiang}",

year = "2018",

month = jun,

doi = "10.3867/j.issn.1000-3002.2018.01.001",

language = "English",

volume = "32",

pages = "1--50",

journal = "Chinese Journal of Pharmacology and Toxicology",

issn = "1000-3002",

publisher = "Chinese Journal of Pharmacology and Toxicology",

number = "1",

}

Jiang, N, Ql, CH, Cao, L, Chen, LY, Gu, JH, Kang, Y, Inkyeom, K, Lian, XY, Lu, Y, Lyu, GY, Nie, K, Ql, Y, Valerie, SK, Michael, S, Cherry, W, Wang, YH, Xiao, W, Yang, Y, Yu, LZ, Zhang, DS, Zhang, YH, Zhou, WX, Du, GH & Zhang, YX 2018, 'New situation and new strategies research and development and internationalization of new drugs and health products of traditional Chinese medicine', Chinese Journal of Pharmacology and Toxicology, vol. 32, no. 1, pp. 1-50. https://doi.org/10.3867/j.issn.1000-3002.2018.01.001

TY - JOUR

T1 - New situation and new strategies research and development and internationalization of new drugs and health products of traditional Chinese medicine

AU - Jiang, Ning

AU - Ql, Chun Hui

AU - Cao, Liang

AU - Chen, Lan Ying

AU - Gu, Jin Hui

AU - Kang, Yong

AU - Inkyeom, Kim

AU - Lian, Xiao Yuan

AU - Lu, Yin

AU - Lyu, Gui Yuan

AU - Nie, Ke

AU - Ql, Yun

AU - Valerie, Schini Kerth

AU - Michael, Spedding

AU - Cherry, Wainwright

AU - Wang, Yue Hua

AU - Xiao, Wei

AU - Yang, Yong

AU - Yu, Lin Zhong

AU - Zhang, Dan Shen

AU - Zhang, Yong He

AU - Zhou, Wen Xia

AU - Du, Guan Hua

AU - Zhang, Yong Xiang

PY - 2018/6

Y1 - 2018/6

N2 - The 2017 China (Lianyungang) International Medical Technology Conference v/as held in Lianyungang. Jiangsu Province during November 15-17, 2017. During this conference, the Division for Traditional Chinese Medicine and Natural Products Pharmacology of Chinese Pharmacological Society (CNPHARS) and Jiangsu Kanion Pharmaceutical Co. Ltd. jointly held the Forum on R&D and Internationalization of New Drugs and Health Products of Traditional Chinese Medicine. The forum was co-chaired by Professor ZHANG Yong- xiang, President of CNPHARS, Chair of Division for Tradhional Chinese Medicine and Natural Products Pharmacology of CNPHARS, and Chair of the Natural Product Section of International Union of Basic & Clinical Pharmacology (IUPHAR), Professor DU Guan-hua, former President of CNPHARS and Vice-Chair of Division for Traditional Chinese Medtane and Natural Prodjcts Pharmacology of CNPHARS. and Dr. XIAO Wei. Chairman of the Board of Jiangsu Kanion Pharmaceutical Co. Ltd. and Vice-Chair of Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS. More than 70 scholars attended the forum, including four foreign experts [Michael SPEDDING. Secretary- General ol IUPHAR; Professor Valerie B. SCHINI-KERTH, Vice-Chair of the Natural Product Section of IUPHAR; Professor Cherry WAINWRGHT. Director of Centre for Natural Product Drugs of Robert Gordon University; Professor InKyeom KIM, Director of the Korean Society of Pharmacology], members of the Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS and leading researchers at Jiangsu Kanion Pharmaceutical Co., Ltd. GU Jin-hui, Director of the Division of National Science and Technology Major Project for Drug Innovation, Department of Health Science, Technology and Education, National Health and Family Planning Commission of the People's Republic of China v/as also invited to attend the forum. Representatives discussed the R&D and internationalization of new drugs and health products of traditional Chinese medicine. The summary of views and advice of some experts was published here for the purpose of promoting domestic and overseas academic exchange, and playing an active role in improving the level of R&D and internationalization of new drugs and health products of traditional Chinese medicine In China.

AB - The 2017 China (Lianyungang) International Medical Technology Conference v/as held in Lianyungang. Jiangsu Province during November 15-17, 2017. During this conference, the Division for Traditional Chinese Medicine and Natural Products Pharmacology of Chinese Pharmacological Society (CNPHARS) and Jiangsu Kanion Pharmaceutical Co. Ltd. jointly held the Forum on R&D and Internationalization of New Drugs and Health Products of Traditional Chinese Medicine. The forum was co-chaired by Professor ZHANG Yong- xiang, President of CNPHARS, Chair of Division for Tradhional Chinese Medicine and Natural Products Pharmacology of CNPHARS, and Chair of the Natural Product Section of International Union of Basic & Clinical Pharmacology (IUPHAR), Professor DU Guan-hua, former President of CNPHARS and Vice-Chair of Division for Traditional Chinese Medtane and Natural Prodjcts Pharmacology of CNPHARS. and Dr. XIAO Wei. Chairman of the Board of Jiangsu Kanion Pharmaceutical Co. Ltd. and Vice-Chair of Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS. More than 70 scholars attended the forum, including four foreign experts [Michael SPEDDING. Secretary- General ol IUPHAR; Professor Valerie B. SCHINI-KERTH, Vice-Chair of the Natural Product Section of IUPHAR; Professor Cherry WAINWRGHT. Director of Centre for Natural Product Drugs of Robert Gordon University; Professor InKyeom KIM, Director of the Korean Society of Pharmacology], members of the Division for Traditional Chinese Medicine and Natural Products Pharmacology of CNPHARS and leading researchers at Jiangsu Kanion Pharmaceutical Co., Ltd. GU Jin-hui, Director of the Division of National Science and Technology Major Project for Drug Innovation, Department of Health Science, Technology and Education, National Health and Family Planning Commission of the People's Republic of China v/as also invited to attend the forum. Representatives discussed the R&D and internationalization of new drugs and health products of traditional Chinese medicine. The summary of views and advice of some experts was published here for the purpose of promoting domestic and overseas academic exchange, and playing an active role in improving the level of R&D and internationalization of new drugs and health products of traditional Chinese medicine In China.

KW - Health products

KW - Internationalization

KW - New drugs

KW - Traditional Chinese medicine

UR - http://www.scopus.com/inward/record.url?scp=85049693777&partnerID=8YFLogxK

U2 - 10.3867/j.issn.1000-3002.2018.01.001

DO - 10.3867/j.issn.1000-3002.2018.01.001

M3 - Review article

AN - SCOPUS:85049693777

SN - 1000-3002

VL - 32

SP - 1

EP - 50

JO - Chinese Journal of Pharmacology and Toxicology

JF - Chinese Journal of Pharmacology and Toxicology

IS - 1

ER -

New situation and new strategies research and development and internationalization of new drugs and health products of traditional Chinese medicine

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this